Skip to main content

Animations

MJFF Publications

5581 - 5590 of 8824 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2020
  • 2020
  • 2019
  • 2019
  • 2020
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Altered dynamics of visual contextual interactions in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0085-5
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-45896-4
    Citation Count: 25
  • Summary Details
    OPEN
    Title: To be or not to be pink(1): contradictory findings in an animal model for Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcz016
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Subcortical Intermittent Theta-Burst Stimulation (iTBS) Increases Theta-Power in Dorsolateral Prefrontal Cortex (DLPFC)
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00041
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2020.00033
    Citation Count: 86
  • Summary Details
    RESTRICTED
    Title: Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000008699
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.201
    Citation Count: 120
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-59414-4
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00702-019-02125-6
    Citation Count: 21
  • Summary Details
    OPEN
    Title: The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-019-02066-0
    Citation Count: 104
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.